MDT · News · 20260916N

Management Changes

Medtronic plc · 2026-09-16 · Importance 31 · Surprise 42

Medtronic appointed Lara Barghout as president of its Interventional Cardiology Therapies operating unit on September 16, 2026. Barghout previously served as CEO of Recor Medical and led development of the Paradise renal-denervation device through its FDA approval. Her appointment follows a reorganization of Medtronic’s cardiovascular portfolio and the departure of leaders in the renal-denervation segment.

Key facts

• Medtronic appointed Lara Barghout as president of Medtronic’s Interventional Cardiology Therapies operating unit. source
• Lara Barghout's appointment follows a reorganization of Medtronic's cardiovascular portfolio and the departure of key leaders in its renal denervation segment. source
• Sandra Cohen Kalter served as Vice President and Chief Regulatory Counsel of Medtronic plc. source